OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets
Vladimir Laletin, P Bernard, Cathy Costa Da Silva, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e005845-e005845
Open Access | Times Cited: 14
Vladimir Laletin, P Bernard, Cathy Costa Da Silva, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e005845-e005845
Open Access | Times Cited: 14
Showing 14 citing articles:
CAR-T cell therapy for hematological malignancies: History, status and promise
Chao Wang, Jianpeng Wang, Shusheng Che, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21776-e21776
Open Access | Times Cited: 24
Chao Wang, Jianpeng Wang, Shusheng Che, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21776-e21776
Open Access | Times Cited: 24
Integrative network analysis of transcriptomics data reveals potential prognostic biomarkers for colorectal cancer
Mohita Mahajan, Angshuman Sarkar, Sukanta Mondal
Cancer Medicine (2024) Vol. 13, Iss. 11
Open Access | Times Cited: 4
Mohita Mahajan, Angshuman Sarkar, Sukanta Mondal
Cancer Medicine (2024) Vol. 13, Iss. 11
Open Access | Times Cited: 4
Cbl-b inhibition improves manufacturing efficiency and antitumoral efficacy of anti-CD19 CAR-T cells
Hao‐Qi Wang, Fei Li, Yuanyuan Feng, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113971-113971
Closed Access
Hao‐Qi Wang, Fei Li, Yuanyuan Feng, et al.
International Immunopharmacology (2025) Vol. 147, pp. 113971-113971
Closed Access
RESET: A reversible TCR-coupled antigen receptor with superior targeting sensitivity and pharmacologically controlled anti-tumor activity
Jardin Leleux, Jillian Rosenberg, Olmo Sonzogni, et al.
Molecular Therapy (2025)
Open Access
Jardin Leleux, Jillian Rosenberg, Olmo Sonzogni, et al.
Molecular Therapy (2025)
Open Access
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligands
Aude G. Chapuis, Shihong Zhang, Tzu-Hao Tang, et al.
Research Square (Research Square) (2025)
Closed Access
Aude G. Chapuis, Shihong Zhang, Tzu-Hao Tang, et al.
Research Square (Research Square) (2025)
Closed Access
Molecular Mechanisms Governing CD8 T Cell Differentiation and Checkpoint Inhibitor Response in Cancer
L Rausch, Axel Kallies
Annual Review of Immunology (2025) Vol. 43, Iss. 1, pp. 515-543
Closed Access
L Rausch, Axel Kallies
Annual Review of Immunology (2025) Vol. 43, Iss. 1, pp. 515-543
Closed Access
Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of Cancer
Jingjing Peng, Xiaoyu Ding, Celia Y. Chen, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
Jingjing Peng, Xiaoyu Ding, Celia Y. Chen, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
IQGAP3 promotes the progression of glioma as an immune and prognostic marker
Xiaofeng Gao, Juanjuan Ge, Xuzheng Gao, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 4, pp. 659-678
Open Access | Times Cited: 2
Xiaofeng Gao, Juanjuan Ge, Xuzheng Gao, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 4, pp. 659-678
Open Access | Times Cited: 2
Molecular mechanism of specific HLA-A mRNA recognition by the RNA-binding-protein hMEX3B to promote tumor immune escape
Kanglong Yang, Guanglin Chen, Fan Yu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
Kanglong Yang, Guanglin Chen, Fan Yu, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 2
DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killing
В. М. Лалетин, P Bernard, Camille Montersino, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
В. М. Лалетин, P Bernard, Camille Montersino, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Zhouchi Yao, Yayun Zeng, Cheng Liu, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
BTLA and PD-1 signals attenuate TCR-mediated transcriptomic changes
Muhammad Zainul Arifin, Judith Leitner, Donagh Egan, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110253-110253
Open Access | Times Cited: 1
Muhammad Zainul Arifin, Judith Leitner, Donagh Egan, et al.
iScience (2024) Vol. 27, Iss. 7, pp. 110253-110253
Open Access | Times Cited: 1
Serum cell division cycle 42 reflects the treatment response and survival in patients with advanced cervical cancer who receive immune checkpoint inhibitor treatment
Lili Guo, Yue Su, Xiaoyu Liu, et al.
Oncology Letters (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 3
Lili Guo, Yue Su, Xiaoyu Liu, et al.
Oncology Letters (2023) Vol. 26, Iss. 3
Open Access | Times Cited: 3
IL2RG’s Expression and its associated Long Non-Coding RNAs signature in ccRCC: Development, Validation, and Im-plications for Diagnosis,Prognosis,and Treatment
Weijing Hu, Yongquan Chen, Xiaoling Guo, et al.
Research Square (Research Square) (2024)
Open Access
Weijing Hu, Yongquan Chen, Xiaoling Guo, et al.
Research Square (Research Square) (2024)
Open Access
